Home > Analyse
Actualite financiere : Actualite bourse

Nicox: collaboration agreement with Re-Vana.

(CercleFinance.com) - The international ophthalmic company Nicox has announced that it has concluded a research collaboration agreement with Re-Vana Therapeutics Ltd, Re-Vana Therapeutics Ltd, a UK ocular pharmaceutical and drug delivery company.

This non-exclusive collaboration will focus on the development of EyeLief, an extended-release drug delivery platform, applied to Nicox's new generation pure nitrous oxide donors.

Copyright (c) 2017 CercleFinance.com. All rights reserved.